June 5, 2026 01:49 PM EDTUpdated 02:12 PM FDA+ Industry seeks more clarity on commissioner's voucher program Zachary Brennan Senior Editor The pharma industry and rare disease advocates voiced concerns about the transparency and fairness of the Commissioner’s National Priority Voucher pilot program. The program faces … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
81 words · extracted 1mo agoread original ↗
comments(0)
5-min edit window · permanent after that